sulfadiazine has been researched along with Lipodystrophy, Intestinal in 2 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fenollar, F | 2 |
| Perreal, C | 1 |
| Raoult, D | 2 |
| Bakkali, N | 1 |
| Rolain, JM | 1 |
2 other studies available for sulfadiazine and Lipodystrophy, Intestinal
| Article | Year |
|---|---|
Tropheryma whipplei natural resistance to trimethoprim and sulphonamides in vitro.
Topics: Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Sulfadiazine; Trimethopri | 2014 |
Comment on: therapy for Whipple's disease.
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Sulfadiazine; Tropheryma; Whipple Diseas | 2008 |